Literature DB >> 3986739

Gonadal effects of cancer therapy in girls.

S V Nicosia, M Matus-Ridley, A T Meadows.   

Abstract

The gonadal histology of 21 prepubertal, intrapubertal, and postpubertal girls who died 1 day to 2 months after cessation of therapy for extragonadal solid tumors was reviewed. In addition to focal or diffuse cortical fibrosis, a reduction in follicle numbers and impaired follicular maturation were observed in cancer patients independent of their pubertal age. These changes appeared to be more severe in malnourished patients and in girls who received multiple agent chemotherapy, with or without irradiation. Both before and after the age of 10 years, most cancer patients had a total number of follicles similar to that of age- and nutrition-matched controls. However, the majority of these girls displayed impaired follicular maturation as demonstrated by reduced numbers of growing and antral follicles compared to controls. Histologic evidence of ovarian damage suggests that the future reproductive performance may be impaired in some female cancer patients treated even before puberty.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986739     DOI: 10.1002/1097-0142(19850515)55:10<2364::aid-cncr2820551011>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

1.  Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors.

Authors:  H Irene Su; Mary D Sammel; Luke Velders; Michelle Horn; Corrie Stankiewicz; Jennifer Matro; Clarisa R Gracia; Jamie Green; Angela DeMichele
Journal:  Fertil Steril       Date:  2009-04-18       Impact factor: 7.329

Review 2.  Chemotherapy-induced damage to ovary: mechanisms and clinical impact.

Authors:  Giuliano Bedoschi; Paula Andrea Navarro; Kutluk Oktay
Journal:  Future Oncol       Date:  2016-07-12       Impact factor: 3.404

3.  Gonadal function of young adults after therapy of malignancies during childhood or adolescence.

Authors:  H L Müller; M Klinkhammer-Schalke; B Seelbach-Göbel; A A Hartmann; J Kühl
Journal:  Eur J Pediatr       Date:  1996-09       Impact factor: 3.183

Review 4.  Roles of reactive oxygen species and antioxidants in ovarian toxicity.

Authors:  Patrick J Devine; Sally D Perreault; Ulrike Luderer
Journal:  Biol Reprod       Date:  2012-02-09       Impact factor: 4.285

Review 5.  Clinical cases in oncofertility.

Authors:  Laxmi A Kondapalli; Fanzhen Hong; Clarisa R Gracia
Journal:  Cancer Treat Res       Date:  2010

6.  Menstrual restoration in severe panhypopituitarism many years after cranial irradiation for suprasellar germinoma.

Authors:  Masanobu Ito; Ichiro Iwamoto; Hirofumi Hirano; Tsutomu Douchi
Journal:  Reprod Med Biol       Date:  2014-11-29

7.  Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer.

Authors:  Mary E Abusief; Stacey A Missmer; Elizabeth S Ginsburg; Jane C Weeks; Ann H Partridge
Journal:  Fertil Steril       Date:  2012-01       Impact factor: 7.329

Review 8.  Fertility preservation and management of gonadal failure associated with lymphoma therapy.

Authors:  Simon J Howell; Stephen M Shalet
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

9.  Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.

Authors:  Hui-Chun Irene Su; Carolyn Haunschild; Karine Chung; Sara Komrokian; Sarah Boles; Mary Dupuis Sammel; Angela DeMichele
Journal:  Cancer       Date:  2014-07-31       Impact factor: 6.860

Review 10.  Preservation of fertility in women undergoing chemotherapy: current approach and future prospects.

Authors:  R Abir; B Fisch; A Raz; S Nitke; Z Ben-Rafael
Journal:  J Assist Reprod Genet       Date:  1998-09       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.